Replies to post #43843 on Sunshine Biopharma Inc (SBFM)

[Lavaliotis]

Couldn’t agree with you more,

SBFMd’s Track Record proves a lot about management and is very consistent.

Financing:
Duchess - Fail
Jitney - Fail
GHS - cancelled, Fail

First Batch manufacturing
Lonza pharma Fail
Garmen Labs - Fail
Crocus pharma - no news and a major reduction over the 800k requested by Lonza another fabrication to make it look better.

Acquisitions
Garmen Labs - Fail
Atlas labs - No news no revenues, Fail

Clinical Trials
Jewish Hospital - No news, no updates
TBD

Announcement of 4 new DIN applications since 2015 still no news no updates - Fail
Essential 9TM natural product- no sales no follow up as promised!

It’s all clear and consistent - fabricating stories to P&D and fill their pockets.